Improving a Pharmaceutical Water System based on a Risk Analysis Approach - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Improving a Pharmaceutical Water System based on a Risk Analysis Approach
In this study, fault tree analysis applied to a water pretreatment and purification installation exposed cause-and-effect complex interrelations in possible fault events.


Pharmaceutical Technology


Arturo Toledo Rivero, PhD,* is a chemical engineer and head of the R&D department at Liorad Laboratories, Ave. 27A No. 26402, La Lisa, Havana, Cuba, tel. +537 2717935, fax +537 2717899,
Nelson Sierra Prado is a microbiologist and head of the validation group, QA department; Anamarys González Alvarez is a chemical engineer and pharmaceutical specialist at the R&D department; and Danelys Cardoza Lobaina is a chemical engineer and quality engineering specialist in the QA department, all at Liorad Laboratories.

*To whom all correspondence should be addressed.

Submitted: Aug. 8, 2007 Accepted: Aug. 20, 2007

References

1. US Pharmacopoeia, Spanish Edition (US Pharmacopeial Convention, Rockville, MD, 2007), pp. 1428–1432.

2. European Pharmacopoeia 5.0 ed. (European Pharmacopoeia, 2005), pp. 2692–2698.

3. ISPE Baseline, Pharmaceutical Engineering Guides for New and Renovated Facilities, vol. 4 (Jan. 2001).

4. US Pharmacopeia, Spanish Edition (US Pharmacopeial Convention, Rockville, MD, 2007), pp. 763–764.

5. B. Dodson and D. Nolan, Reliability Engineering Handbook (1998).

6. US Food and Drug Administration, Pharmaceutical CGMPs for the Twenty-First Century, a Risk-Based Approach (Sept. 2004).

7. ICH Harmonized Tripartite Guideline, Q9: Quality Risk Management (Nov. 9, 2005).

8. R.L. Browning, "Industrial Risk Analysis," Chem. Eng. 109–114, (Oct. 20, 1969).

9. R.L. Browning, "Loss Analysis for Improving Protective Instrumentation Process," Instrument. Technol. 14 (10), 84–90 (1972).

10. P.A. Crossete, "Fault Tree Analysis for System Reliability," Instrument. Technol. 13 (8), 52–56 (1971)

11. "Análisis de Riesgo [Risk Analysis]" http://www.unizar.es/guiar/1/Accident/Rd1254/An_riesgo.htm#Identifica, accessed Oct. 15, 2007.

12. NASA Lewis Research Center, "Fault Tree Analysis (FTA)," available at http:// http://www.hq.nasa.gov/office/codeq/software/ComplexElectronics/techniques/fault-tree.htm, accessed Oct. 15, 2007.

13. NASA Lewis Research Center, "Failure Mode and Effect Analysis," available at http:// http://www.hq.nasa.gov/office/codeq/software/ComplexElectronics/techniques/fmea.htm, accessed Oct. 15, 2007.

14. W. Monroe Keyserling, "Failure Modes and Effects Analysis (FMEA)," IOE 539 Notes, Industrial and Operations Engineering, University of Michigan, Jul. 21, 2000.

15. Kaiser Permanente, "Failure Modes and Effects Analysis (FMEA)," Team Instruction Guide, Mar. 2002.

16. Diputación Foral de Bizkaia, "AMFE: Análisis Modal de Fallos y Efectos," Librería HOR DAGO, Nov. 7, 2004.

17. Water System Revalidation Protocol, Liorad Laboratories, code P.R.S.06.06, Dec. 2006.

18. Water System Performance Qualification (PQ) Report, Liorad Laboratories, code I.P.R.S.06.06, Mar. 2007.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Source: Pharmaceutical Technology,
Click here